Compare ONCY & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONCY | AMTX |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.0M | 98.6M |
| IPO Year | 1999 | N/A |
| Metric | ONCY | AMTX |
|---|---|---|
| Price | $1.12 | $1.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $6.00 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 1.2M | 860.1K |
| Earning Date | 03-06-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $201,323,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $139.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.33 | $1.22 |
| 52 Week High | $1.51 | $3.66 |
| Indicator | ONCY | AMTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 64.39 |
| Support Level | $0.98 | $1.43 |
| Resistance Level | $1.30 | $1.62 |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 52.63 | 97.67 |
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.